行情

CDXS

CDXS

Codexis
NASDAQ

实时行情|Nasdaq Last Sale

11.16
+0.26
+2.39%
盘后: 11.16 0 0.00% 16:41 03/31 EDT
开盘
10.87
昨收
10.90
最高
11.33
最低
10.66
成交量
55.12万
成交额
--
52周最高
22.38
52周最低
8.43
市值
6.57亿
市盈率(TTM)
-51.0755
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CDXS价格均价为20.58,最高价位25.00,最低价为15.00。

EPS

CDXS 新闻

更多
  • Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders
  • GlobeNewswire · 03/23 12:00
  • Codexis inks deal with Takeda to advance gene therapies for rare genetic disorders
  • Seeking Alpha - Article · 03/23 11:40
  • Edited Transcript of CDXS earnings conference call or presentation 27-Feb-20 9:30pm GMT
  • Thomson Reuters StreetEvents · 03/13 18:57
  • Jefferies likes United Therapeutics in premarket analyst action
  • Seeking Alpha - Article · 03/10 11:56

所属板块

生物技术和医学研究
-0.26%
制药与医学研究
-0.17%

热门股票

代码
价格
涨跌幅

CDXS 简况

Codexis, Inc. is a protein engineering company. The Company is engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The Company operates through its two segments, such as the performance enzymes and novel biotherapeutics. It provides enzyme optimization services from small scale through to commercial quantities and also develops biocatalyst products. It is also engaged in the development of manufacturing processes for active pharmaceutical ingredients, fine chemicals and food ingredients. Its CodeEvolver is a protein engineering technology platform and products in the pharmaceuticals market. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical.
展开

微牛提供Codexis, Inc.(NASDAQ-CDXS)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CDXS股票新闻,以帮助您做出投资决策。